Differential effects of propofol and sevoflurane on ischemia-induced ventricular arrhythmias and phosphorylated connexin 43 protein in rats

Anesthesiology

Volumn 110, Issue 1, 2009, Pages 50-57

  Hirata, Naoyuki ^a   Kanaya, Noriaki ^a   Kamada, Noriko ^a   Kimura, Saori ^a   Namiki, Akiyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; PHOSPHOPROTEIN; PROPOFOL; SEVOFLURANE; ETHER DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; ANIMAL; COMPARATIVE STUDY; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE FIBRILLATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CONNEXIN 43; HEART RATE; MALE; METHYL ETHERS; MYOCARDIAL ISCHEMIA; PHOSPHORYLATION; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FIBRILLATION;

EID: 58749112235     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318190b537     Document Type: Article

References (51)

1. Atlee JL 3rd, Bosnjak ZJ: Mechanisms for cardiac dysrhythmias during anesthesia. ANESTHESIOLOGY 1990; 72:347-74
2. Mathur S, Farhangkhgoee P, Karmazyn M: Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: Role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). ANESTHESIOLOGY 1999; 91:1349-60
3. Rubart M, Zipes DP: Mechanisms of sudden cardiac death. J Clin Invest 2005; 115:2305-15
4. Smith WTIV, Fleet WF, Johnson TA, Engle CL, Cascio WE: The 1b phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Circulation 1995; 92:3051-60
5. Saffits JE, Schuessler RB, Yamada KA: Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. Cardiovasc Res 1999; 42:309-17
6. Dhein S, Polontchouk L, Salameh A, Haefliger JA: Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40. Biol Cell 2002; 94:409-22
7. Peters NS, Green CR, Poole-Wilson PA, Severs NJ: Reduced content of connexin 43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88:864-75
8. Poelzing S, Rosenbaum DS: Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol 2004; 287:H1762-70
9. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, Saffitz JE: Dephosphorylation and intracellular redistribution of ventricular connexin 43 during electrical uncoupling induced by ischemia. Circ Res 2000; 87:656-62
10. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK: Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007; 450:819-24
11. Carmichael FJ, Crawford MW, Khayyam N, Saldivia V: Effect of propofol infusion on splanchnic hemodynamics and liver oxygen consumption in the rat. A dose-response study. ANESTHESIOLOGY 1993; 79:1051-60
12. Taheri S, Halsey MJ, Liu J, Eger EI 2nd, Koblin DD, Laster MJ: What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991; 72:627-34
13. Perlstein I, Hoffman A: Cumulative plot of heart rate variability spectrum assesses kinetics of action of cholinergic drugs in rats. Am J Physiol 2000; 279:H110-5
14. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DC, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B: The Lambeth convention: Guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 1988; 22:224-55
15. Leenen FH, Yuan B: Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats. Hypertension 2001; 37:209-15
16. Burjorjee JE, Milne B: Propofol for electrical storm; a case report for cardioversion and suppression of ventricular tachycardia by propofol. Can J Anaesth 2002; 49:973-7
17. Miro O, de la Red G, Fontanals J: Cessation of paroxysmal atrial fibrillation during acute intravenous propofol administration (letter). ANESTHESIOLOGY 2000; 92:910
18. Hermann R, Vettermann J: Change of ectopic supraventricular tachycardia to sinus rhythm during administration of propofol. Anesth Analg 1992; 75:1030-2
19. Hanouz JL, Yvon A, Flais F, Rouet R, Ducoret P, Bricard H, Gerard JL: Propofol decreases reperfusion-induced arrhythmias in a model of "border zone" between normal and ischemic-reperfused guinea pig myocardium. Anesth Analg 2003; 97:1230-8
20. Alphin RS, Martens JR, Dennis DM: Frequency-dependent effects of propo- fol on atrioventricular nodal conduction in guinea pig isolated heart. Mechanism and potential antidysrhythmic properties. ANESTHESIOLOGY 1995; 83:382-94
21. Pires LA, Huang SK, Wagshal AB, Kulkarni RS: Electrophysiological effects of propofol on the normal cardiac conduction system. Cardiology 1996; 87: 319-24
22. Jardine DL, Charles CJ, Frampton CM, Richards AM: Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model. Am J Physiol 2007; 293:433-9
23. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen PS: Nerve sprouting and sudden cardiac death. Circ Res 2000; 86:816-21
24. Liu YB, Wu CC, Lu LS, Su MJ, Lin CW, Lin SF, Chen LS, Fishbein MC, Chen PS, Lee YT: Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 2003; 92:1145-52
25. Heath BM, Xia J, Dong E, An RH, Brooks A, Liang C, Federoff HJ, Kass RS: Overexpression of nerve growth factor in the heart alters ion channel activity and beta-adrenergic signaling in an adult transgenic mouse. J Physiol 1998; 512: 779-91
26. Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Eng J Med 1988; 339:489-97
27. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM: Treating electrical storm. Sympathetic blockade versus advanced cardiac life supportguided therapy. Circulation 2000; 102:742-7
28. Scott NB, Turfrey DJ, Ray DA, Nzewi O, Sutcliffe NP, Lal AB, Norrie J, Nagels WJ, Ramayya GP: A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 2001; 93:528-35
29. Azuma M, Matsumura C, Kenmotsu O: Inotropic and electrophysiologic effects of propofol and thiamylal in isolated papillary muscles of the guinea pig and the rat. Aneth Analg 1993; 77:557-63
30. Buljubasic N, Marijic J, Berczi V, Supan DF, Kampine JP, Bosnjak ZJ: Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. ANESTHESIOLOGY 1996; 85: 1092-9
31. Guenoun T, Montagne O, Laplace M, Crozatier B: Propofol-induced modifications of cardiomyocyte calcium transient and sarcoplasmic reticulum function in rats. ANESTHESIOLOGY 2000; 2:542-9
32. Deutsch N, Klitzner TS, Lamp ST, Weiss JN: Activation of the ATP-sensitive K current during hypoxia in rabbit ventricular papillary muscle: Correlation with tissue ATP levels. Am J Physiol 1991; 261:H671-6
33. Kupersmith J, Li ZY, Maldonado C: Marked action potential prolongation as a source of injury current leading to border zone arrhythmogenesis. Am Heart J 1994; 127:1543-53
34. Kokita N, Hara A, Abiko Y, Arakawa J, Hashisume H, Namiki A: Propofol improves functional and metabolic recovery in ischemia reperfused isolated rat hearts. Anesth Analg 1998; 86:252-8
35. Kobayashi I, Kokita N, Namiki A: Propofol attenuates ischemia-reperfusion injury in the rat heart in vivo. Eur J Anaesthesiol 2008; 25:144-51
36. Kevin LG, Katz P, Camara AK, Novalija E, Riess ML, Stowe DF: Anesthetic preconditioning: Effects on latency to ischemic injury in isolated hearts. ANESTHESIOLOGY 2003; 99:385-91
37. Park WK, Pancrazio JJ, Suh CK, Lynch C 3rd : Myocardial depressant effect of sevoflurane: Mechanical and electrophysiologic actions in vitro. ANESTHESIOLOGY 1996; 84:1166-76
38. Chae JE, Ahn DS, Kim MH, Lynch C 3rd, Park WK: Electrophysiologic mechanism underlying action potential prolongation by sevoflurane in rat ventricular myocytes. ANESTHESIOLOGY 2007; 107:67-74
39. Picker O, Scheeren TW, Arndt JO: Inhalation anaesthetics increase heart rate by decreasing cardiac vagal activity in dogs. Br J Anaesth 2001; 87:748-54
40. Paisansathan C, Lee M, Hoffman WE, Wheeler P: Sevoflurane anesthesia decreases cardiac vagal activity and heart rate variability. Clin Auton Res 2007; 17:370-4
41. Naruo H, Onizuka S, Prince D, Takasaki M, Syed NI: Sevoflurane blocks cholinergic synaptic transmission postsynaptically but does not affect short-term potentiation. ANESTHESIOLOGY 2005; 102:920-8
42. Kanaya N, Hirata N, Kurosawa S, Nakayama M, Namiki A: Differential effects of propofol and sevoflurane on heart rate variability. ANESTHESIOLOGY 2003; 98:34-40
43. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE: Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43- deficient mice. Circulation 2000; 101:547-52
44. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI: Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001; 88:333-9
45. Fiolet JW, Baartscheer A, Schumacher CA, Coronel R, ter Welle HF: The change of the free energy of ATP hydrolysis during global ischemia and anoxia in the rat heart. J Mol Cell Cardiol 1984; 16:1023-36
46. Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, Muramoto K, Sato T: Efferent vagal nerve stimulation protects hearts against ischemia-induced arrhythmia by preserving connexin 43 protein. Circulation 2005; 112:164-70
47. Valoli E, De Feffafi GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ: Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68:1471-81
48. van Koppen CJ, Kaiser B: Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 2003; 98:197-220
49. Yuan W, Ginsburg KS, Bers DM: Comparison of sarcolemmal calcium channel current in rabbit and rat ventricular myocytes. J Physiol 1996; 493: 733-46
50. Kanaya N, Kimura H, Nakayama M, Tsuchida H, Ohshika H, Namiki A: The direct effect of halothane on myocardial contraction in rat myocytes with poorly developed gap junctional intercellular communication. Acta Anaesthesiol Scand 1999; 43:91-6
51. He DS, Burt JM: Mechanism and selectivity of the effects of halothane on gap junction channel function. Circ Res 2000; 86:E104-9